Generex and RXi partnered to use RXi's RNAi technology to develop vaccine formulations for active immunotherapy to treat cancer

RXi Pharmaceuticals Corp.

U.S. / Small-Cap Biopharma (<$1 billion)

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Generex Biotechnology Corp.

Canada / Small-Cap Biopharma (<$1 billion)

$34.1m on 08/05/2011 [market cap]

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced